
Adacyte Therapeutics is a multinational company committed to the development of unique health technologies aimed at improving patients' health and its quality of life. Adacyte was established in 2018 with the commitment and responsibility to commercialize internationally a selective apheresis system with proven clinical efficacy for the treatment of certain autoimmune pathologies. Our patients inspire and guide us. What is important for them is also important for us. Their safety is our obsession and for that reason we develop medical devices that enable to address serious health problems. We…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.